The use of marker vaccines in eradication of herpesviruses
- 1 January 1996
- journal article
- research article
- Published by Elsevier in Journal of Biotechnology
- Vol. 44 (1-3) , 75-81
- https://doi.org/10.1016/0168-1656(95)00129-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Genetic recombination of pseudorabies virus: evidence that homologous recombination between insert sequences is less frequent than between autologous sequencesArchiv für die gesamte Virusforschung, 1995
- An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiationVaccine, 1995
- Intensive regional vaccination with a gI-deleted vaccine markedly reduces pseudorabies virus infectionsVaccine, 1994
- A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattleVaccine, 1994
- A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccineVaccine, 1994
- Efficacy of a Deletion Mutant Bovine Herpesvirus-1 (BHV-1) Vaccine That Allows Serologic Differentiation of Vaccinated from Naturally Infected AnimalsJournal of Veterinary Diagnostic Investigation, 1993
- Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cellsVaccine, 1993
- Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strainJournal of General Virology, 1990
- Induction of antibodies to glycoprotein I in pigs exposed to different doses of a mildly virulent strain of Aujeszky's disease virusPublished by Wiley ,1988
- Differentiation of Serum Antibodies from Pigs Vaccinated or Infected with Aujeszky's Disease Virus by a Competitive Enzyme ImmunoassayJournal of General Virology, 1986